Our work described here shows that the genetically tractable S. cerevisiae is a very useful model system to study the pathologically toxic human Top1 mutants arising in CPT-treated cancer cells and can lead to better understanding of the mechanism of G4-associated genome instability and potential secondary cancers linked to these drug-resistant mutant proteins. This evidence concerns the gene TOP1 and cancer.